Search

Search Constraints

You searched for: Subject NSCLC -- RANK -- RANKL -- Denosumab

Search Results

1. Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. (January 2023)